Gut bacteria patterns differed across the diseases studied, while lupus and inflammatory bowel disease had notable similarities.
Researchers compared gut bacteria data from people with six diseases in which the immune system attacks the body. These included MS, lupus, and inflammatory bowel disease. They also compared the data with gut bacteria data from people with colorectal cancer. Gut bacteria patterns differed across the diseases, but lupus and inflammatory bowel disease had notable similarities. Lab tests confirmed that some proteins made by gut bacteria can interact with a human protein involved in the body's response to inflammation.
The study used data from people with MS and several other diseases. It included people with lupus, inflammatory bowel disease, and colorectal cancer. MS was one part of a wider comparison, not the main focus. The findings suggest gut bacteria patterns may help researchers study differences among these diseases. The strongest overlap reported was between lupus and inflammatory bowel disease, not MS.
You cannot use these findings to choose an MS treatment. The abstract does not give the number of people whose data were studied. It does not show that gut bacteria caused MS or that changing them would help.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More10/9/2026
A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel
Read More10/9/2026
See how lab-grown nerve cells move a key protein, why this may matter for nerve health, and why the
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of the rheumatic diseases often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.